Skip to content

Prestige Consumer Healthcare PBH Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
HRO
HarrowHROW
Hims & Hers Health logo
Hims & Hers HealthHIMS
Kenvue logo
KenvueKVUE
Abbott logo
AbbottABT
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.24B-34.1%

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's accrued manufacturing costs?
Prestige Consumer Healthcare (PBH) reported accrued manufacturing costs of $10.42M in Q4 2025.
How has Prestige Consumer Healthcare's accrued manufacturing costs changed year-over-year?
Prestige Consumer Healthcare's accrued manufacturing costs decreased by 7.8% year-over-year, from $11.3M to $10.42M.
What is the long-term trend for Prestige Consumer Healthcare's accrued manufacturing costs?
Over 4 years (2021 to 2025), Prestige Consumer Healthcare's accrued manufacturing costs has grown at a 0.2% compound annual growth rate (CAGR), from $14.07M to $14.21M.